Skip to content
Search

Latest Stories

Prescription charge hike is reminder that pharmacy teams are govt's tax collectors: Simon Dukes

The Royal Pharmaceutical Society has objected to the latest NHS prescription charge by calling it totally unacceptable, while the pharmacy negotiator PSNC has said the hike is a reminder that pharmacy teams are being annually used as the government's tax collectors.

The national pharmacy bodies reactions follow the government’s decision to raise the cost of single prescription to £9.35 from April 1 onwards.


The price of a three-month prescription pre-payment certificate (PPC) will move up by 60p to £30.25 and a 12-month PPC will increase £2.20 to £108.10, the Pharmacy Services Negotiating Committee (PSNC) said in an update on Wednesday (Feb 24).

Both the RPS and PSNC have objected to the latest prescription charge hike saying it would ultimately impact the end user, especially those who visit pharmacies frequently.

Claire Anderson, chair of the English Pharmacy Board, said: “Raising prescription charges in England is totally unacceptable. The increase in cost will only add to the highly concerning levels of health inequalities in this country and no-one should be put in a position where they have to go without their medicines because they can’t afford to pay.

By not taking their medicines, people can subsequently become unwell and as a result place more pressure on our health service through hospital admissions. In this current climate, we need to be doing everything we can to ease this pressure and give patients access to their regular medicines without difficulty.

As a member of the Prescription Charges Coalition, we’ll continue to campaign against charges for prescriptions in England, which are free in Scotland, Wales and Northern Ireland. There must be no barrier between a patient and lifesaving medicines.

Hike a reminder that pharmacy teams are government's tax collectors

Commenting on the price hike, PSNC chief executive Simon Dukes said: “The prescription charge increase is our yearly reminder that the government mandates community pharmacy teams to be not only clinicians but also tax collectors. After the year that pharmacy teams have all experienced, the continued use of front-line healthcare staff for this purpose is unwelcome and inappropriate.

It is ironic that the Exchequer is keen to use the high street pharmacy network to collect its prescription tax, yet unwilling to reimburse them their Covid-related costs in keeping pharmacy doors open in order to dispense the medicines in the first place. The Government urgently needs to find an alternative solution to the use of community pharmacy for this purpose.

Meanwhile, pharmacy bodies in England have been calling to scrap prescription charges immediately in line with other UK countries.

Amidst Covid-19 pandemic last year, the PSNC, the British Medical Association, and the Dispensing Doctors’ Association had urged the health secretary Matt Hancock to temporarily scrap the prescription charge to create a smoother and safer prescription procedure.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less